Cerevel Therapeutics Holdings Inc (CERE)

$0.00 $0.00 (0.00%) 4:38 PM 12/13/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $8.19B

  • Day's Range

    - - -

  • Volume

    -

  • 52 Week Low / High

    $38.50 - $44.99

  • PE Ratio

    -

  • PEG Ratio

    -

  • Dividend Frequency

    -

CERE's Dividend
-
Amount
-
Dividend Yield
Nov 30
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
0
Strong Buy
0
Buy
7
Hold
0
Sell
0
Strong Sell
$34.00
Target Price

Company News

  • AbbVie Completes Acquisition of Cerevel Therapeutics — Aug 1st, 2024

    Cerevel's clinical-stage assets complement AbbVie's emerging neuroscience pipeline and leading on-market brands in psychiatry, migraine and Parkinson's disease Emraclidine, a potential best-in-class, next-generation antipsychotic, is in trials designed to be registration enabling for schiz...

Similar Stocks

No similar stocks found.

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free